Bogart Wealth LLC’s Beam Therapeutics BEAM Stock Holding History

Bogart Wealth LLC’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378	Hold	11	–	–	﹤0.01%	1843
2026 Q1	$262	Hold	11	–	–	﹤0.01%	1681
2025 Q4	$305	Hold	11	–	–	﹤0.01%	1523
2025 Q3	$267	Hold	11	–	–	﹤0.01%	1476
2025 Q2	$187	Hold	11	–	–	﹤0.01%	1411
2025 Q1	$215	Hold	11	–	–	﹤0.01%	1348
2024 Q4	$273	Hold	11	–	–	﹤0.01%	1301
2024 Q3	$270	Hold	11	–	–	﹤0.01%	1091
2024 Q2	$258	Hold	11	–	–	﹤0.01%	1080
2024 Q1	$363	Hold	11	–	–	﹤0.01%	1024
2023 Q4	$299	Hold	11	–	–	﹤0.01%	1020
2023 Q3	$265	Hold	11	–	–	﹤0.01%	1034
2023 Q2	$351	Hold	11	–	–	﹤0.01%	1003
2023 Q1	$337	Sell	11 -23	-68%	-$908	﹤0.01%	1056
2022 Q4	$1.33K	Sell	34 -15	-31%	-$672	﹤0.01%	835
2022 Q3	$2K	Buy	49 +15	+44%	+$856	﹤0.01%	810
2022 Q2	$1K	Hold	34	–	–	﹤0.01%	812
2022 Q1	$2K	Hold	34	–	–	﹤0.01%	661
2021 Q4	$3K	Buy	34 +11	+48%	+$942	﹤0.01%	606
2021 Q3	$2K	Buy	+23	New	+$2.31K	﹤0.01%	622

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bogart Wealth LLC's BEAM Position: Q2 2026 in Review

Bogart Wealth LLC held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 11 shares worth $378. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Bogart Wealth LLC first reported a position in BEAM in Q3 2021 and has held it in 20 quarters since. The position peaked at $3K in Q4 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Bogart Wealth LLC held 11 shares of Beam Therapeutics worth $378 as of Q2 2026.
Bogart Wealth LLC left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1843 holding.
Bogart Wealth LLC first reported a position in Beam Therapeutics in Q3 2021 and has held it in 20 quarters since.
Bogart Wealth LLC's Beam Therapeutics position peaked at $3K in Q4 2021.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.